Results 161 to 170 of about 7,825,369 (248)

Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments—A VigiBase Disproportionality Analysis Study

Clinical Pharmacology &Therapeutics, EarlyView.
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian, Floriane Jochum, Elise Dumas, Florence Coussy, Kevin Bihan, Bénédicte Lebrun‐Vignes, Barbara Pistilli, Marc‐Antoine Benderra, Lise Selleret, Laurent Chouchana, Fabien Reyal, Anne‐Sophie Hamy, Paul Gougis   +12 more
wiley   +1 more source

Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial. [PDF]

Brain Commun
Williams T, Magill N, John NA, Bianchi A, Blackstone J, Braisher M, De Angelis F, Calvi A, Apap Mangion S, Wade C, Yiannakas MC, Stutters J, Ricciardi A, Prados Carrasco F, MacManus D, Wheeler-Kingshott CAMG, Barkhof F, Ciccarelli O, Chataway J, the MS-STAT2 investigators, the MS-STAT2 investigators .   +20 more
europepmc   +1 more source

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple Sclerosis. [PDF]

Drugs R D, 2023
Vališ M, Achiron A, Hartung HP, Mareš J, Tichá V, Štourač P, Halusková S, Angelucci F, Pavelek Z.   +8 more
europepmc   +1 more source

Effect of Interferon beta-1b on MRI outcomes in secondary progressive multiple sclerosis. Results of a European multicentre, randomised, double-blind, placebo-controlled trial.

, 1999
Moseley IF, Molyneux PD, FILIPPI , MASSIMO, Barker GJ, Wagner K, Miller DH, the European Study Group on Interferon beta 1b in Secondary Progressive Multiple Sclerosis with, MacManus DG   +7 more
core   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Three-Dimensional Deep Learning with Routine Brain Magnetic Resonance Imaging and Clinical Data for Identification of Secondary Progressive Multiple Sclerosis. [PDF]

Brain Sci
Soleymani M, Oladosu O, Salman S, Rashid M, Bento M, Zhang Y.   +5 more
europepmc   +1 more source

Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review. [PDF]

Front Mol Neurosci, 2023
Pogoda-Wesołowska A, Dziedzic A, Maciak K, Stȩpień A, Dziaduch M, Saluk J.   +5 more
europepmc   +1 more source

Reflex seizures and epilepsy surgery: A network approach case‐based exploration

Epileptic Disorders, EarlyView.
Abstract Context Reflex seizures (RS) are defined by their consistent provocation by specific stimuli, encompassing a broad range from elementary sensory inputs to complex cognitive tasks. While RS are often encountered in clinical practice, their surgical management remains sparsely reported and poorly systematized.
Olivier Aron, Laure Salmon, Nicolas Nguyen, Dènahin Toffa, Sami Obaid, Alexis Robin, Dang Khoa Nguyen   +6 more
wiley   +1 more source

Cognitive function is associated with risk of conversion to secondary progressive multiple sclerosis: A cross-sectional study. [PDF]

PLoS One
Mirmosayyeb O, Mohammadi I, Rajai Firouzabadi S, Vaheb S, Yazdan Panah M, Fuchs TA, Weinstock-Guttman B, Shaygannejad V.   +7 more
europepmc   +1 more source

Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study. [PDF]

Front Neurol, 2023
Tartaglia M, Canevelli M, Malimpensa L, Belvisi D, Baione V, Ferrazzano G, Leodori G, Berardelli A, Conte A.   +8 more
europepmc   +1 more source